Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
Trials|September 19, 2014
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?James M S Wason, Lynne Stecher, Adrian P ManderJournal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P ManderStatistical Methods in Medical Research|December 20, 2011
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expectedJames M S Wason, Adrian P ManderEuropean Journal of Cancer (Oxford, England : 1990)|January 18, 2011
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsJames M S Wason, Adrian P Mander, Tim G EisenStatistics in Medicine|December 6, 2011
Optimal multistage designs for randomised clinical trials with continuous outcomesJames M S Wason, Adrian P Mander, Simon G ThompsonCommunications in Statistics: Theory and Methods|January 7, 2021
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variablesMichael J Grayling, James M S Wason, Adrian P ManderBiometrical Journal. Biometrische Zeitschrift|August 4, 2018
Blinded and unblinded sample size reestimation in crossover trials balanced for periodMichael J Grayling, Adrian P Mander, James M S WasonBiometrical Journal. Biometrische Zeitschrift|August 4, 2018
Blinded and unblinded sample size reestimation procedures for stepped-wedge cluster randomized trialsMichael J Grayling, Adrian P Mander, James M S WasonStatistics in Biopharmaceutical Research|January 10, 2022
Two-Stage Adaptive Designs for Three-Treatment Bioequivalence StudiesMichael J Grayling, Adrian P Mander, James M S WasonStatistics in Medicine|November 8, 2018
Admissible multiarm stepped-wedge cluster randomized trial designsMichael J Grayling, Adrian P Mander, James M S WasonPageof 19